Several recent studies have shown that heterozygous point mutations affecting tyrosine 641 (Y641) within the C-terminal catalytic SET domain of EZH2 have been identified in 22% of germinal center B cell diffuse large-cell B cell lymphomas (DLBCL) and in 7-12% of follicular lymphomas [35, 36]. This evidence concerns the gene EZH2 and follicular lymphoma.